The July RTP180 dove into the world of Artificial Intelligence. AI has been introduced to our society in ways that we may not recognize (such as voice assistance on cellphones). However, there is endless potential for advancement in the field of Artificial Intelligence. Five local experts shared their knowledge about the compelling future of AI and how it can help, or hurt, our society.
Andrew Prince, founder of LiRA, shared his fascination with the potential to integrate computer vision with AI to evaluate data for the health care industry. He suggests that procedures, such as surgical seize management for epilepsy, would only become cheaper, more efficient, and more curable with such advanced technology. Watch his talk here, for more.
Our next speaker, Phaedra Boinodiris works for IBM as a trust in AI business transformation leader. She posed the question: What does it take for a business to trust a decision made by a machine? The basic elements to consider are fairness, data privacy and transparency. Learn more about the good, the bad and the ugly of AI in business applications here.
NCSU Associate Professor Dr. Veljko Dubljevic followed by walking the audience through potential risks that AI-equipped vehicles pose. Dr. Dubljevic warned that there are dangers that range from low-stakes, regarding minor system errors, to high-stakes, such as terrorist control of an autonomous vehicle. Learn more about his take on the ethics of AI in the video.
Next, James Rineer with RTI International discussed harnessing the power of synthetic populations for AI. RTI International has created a program, SynthPop, a representative model of real people and households. When AI is applied to this statistical data, it can be used to simulate and predict patterns in human behavior or health outcomes. Because the studies are based on statistics and data, privacy of individuals is preserved. Hear all about synthetic populations from James in the video.
Our final speaker, Dr. Nicole Kleinstreuer from NIEHS, talked about applying AI in place of living beings for chemical safety testing. One option in this process is the use of tissue chips, which are similar to a computer microchip and model human organs. These electronic representations of human tissue are a safer and more accurate way to test pharmaceutical products than on an actual human. Watch the video to learn more.
We’re offering in-person and virtual registration for the August installation of RTP180 on Digital Marketing. Sign up now to attend, we’re looking forward to seeing you!